Happy Thursday! Remember Saturday? Not too long ago, right? That’s the length of time between now and Election Day. (Incidentally, it’s also the length of time you have left to sign up for our post-election virtual event!)
Quick Hits: Today’s Top Stories
The U.S. Supreme Court will not hear the Pennsylvania GOP’s appeal of the Pennsylvania Supreme Court’s Oct. 19 decision allowing ballots to be counted if they are received up to three days after Nov. 3, even if there is no postmark or the postmark is illegible. Justice Samuel Alito penned a separate statement suggesting that the Supreme Court could rule on the case after the election. The Supreme Court also declined to block an extension of North Carolina’s ballot return deadline. Justice Amy Coney Barret did not partake in either decision because “she has not had time to fully review the parties’ filings.”
The Center for Responsive Politics projects that this election cycle—including races in the House, Senate and the White House—will cost a record $14 billion, which would double the previous record set in 2016.
Germany and France announced new lockdown measures on Wednesday to combat the resurgence of COVID-19 cases and deaths. France’s one-month national lockdown will begin Friday, and will require people to stay indoors while nonessential businesses—including bars and restaurants—remain closed. Germany will require bars, gyms, concert halls, restaurants, and theaters to close down for one month beginning on Monday.
With less than a week until Election Day, 73.3 million Americans have already voted through in-person early voting and by mail-in ballots. Early voting numbers have now reached 53 percent of the total 2016 voter turnout, indicating record high voter participation in 2020.
A Wall Street Journal investigation revealed a key source for ex-British spy Christopher Steele’s dossier investigating connections between the Trump campaign and Russia: Olga Galkina, a disgruntled employee of global tech firm XBT Holding SA, who hoped to implicate her former employer by feeding Steele information.
Regeneron Pharmaceuticals announced positive clinical trial data related to its antibody cocktail therapy for COVID-19. Patients who received the therapy prior to hospitalization were 57 percent less likely to need medical care later. Regulators are evaluating whether to grant the treatment an emergency use authorization. Regeneron said earlier this month, however, that it currently only has about 50,000 doses of the treatment available.
The United States confirmed 81,062 new cases of COVID-19 yesterday per the Johns Hopkins University COVID-19 Dashboard, with 7.7 percent of the 1,052,874 tests reported coming back positive. An additional 1,060 deaths were attributed to the virus on Wednesday, bringing the pandemic’s American death toll to 227,673. According to the COVID Tracking Project, 45,045 Americans are currently hospitalized with COVID-19.


Big Tech and the Election
Longtime Morning Dispatch readers might remember that, about a year ago, we ran an item comparing Twitter and Facebook’s differing approaches to political advertising.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



